Biomarker Technologies Market Size, Trends, Opportunities, Innovations & Forecast till 2026
According to a new report published by KD
Market Insights, titled, "Biomarker
Technologies Market by
Product, Technology, Application, and Indication: Global Opportunity Analysis
and Industry Forecast, 2019 - 2026," the biomarker technologies
market accounted for $21,594 million in 2019 is expected to reach $58,508
million by 2026, registering a CAGR of 13.2% from 2019 to
2026.
Biomarker technologies are techniques that are
used to find out biomarkers. These biomarkers are characteristics, genes, or
molecules which are used to measure the biological parameters of the body.
These biological parameters help in identification of various diseases and can
also be helpful in drug discovery. Different technologies, which are used for
the identification of biomarkers include next generation sequencing, polymerase
chain reactions, immunoassays, and others. These techniques are utilized in various
field of science and are mostly used in identification of different disease
such as cancers, autoimmune diseases, infectious diseases, and others.
Moreover, the use of biomarkers has revolutionized patient treatment, which has
become more personalized leading to better treatment outcomes.
The key factors that drive the growth of the
global Biomarker Technologies Market are rise in prevalence of various
diseases such as cancer, autoimmune diseases, and others. The other factors
that contribute toward the growth of the market include surge in research
related to drug discovery and increase in healthcare expenditure. However, high
initial investments for the discovery of biomarker can hamper the market growth
to a certain extent. Whereas, surge in awareness associated with the need of
early detection of various diseases such as cancers and high growth potential
in emerging economies are anticipated to provide lucrative opportunities in the
market during the forecast period.
On the basis of technology, the immunoassay
segment was a major revenue contributor in 2019 and is expected to maintain its
dominant position throughout the analysis period due to surge in prevalence of
various diseases across the globe. For instance, the rise in prevalence of
cancer contributes to the growth of biomarker technologies market as biomarkers
serve as tools in diagnosis of cancer. Moreover, other diseases such as
diabetes type 1, is highly prevalent worldwide. This factor contributes toward
the growth of the biomarker technologies market. In addition, infectious
diseases such as AIDS, tuberculosis, and others are also diagnosed using
biomarkers. Therefore, the factors above mentioned are responsible for the
growth of this segment. On the other side, next generation sequencing is
expected to be the fastest growing segment during the forecast period as this
technique is highly advantageous due to its property of differentiating between
closely related tumor cells to provide better understanding of the growth of
cancer. Moreover, the rise in research related to cancer worldwide is another
factor that boosts the growth of this market.
According to product, the consumables segment
accounted for the highest market share in 2019, and is anticipated to maintain
this trend during the forecast period, as consumables form an important part of
biomarker testing. Instrument segment is the fastest growing segment during the
forecast period owing to the technological advancements.
In 2019, North America accounted for the major
share of biomarker technologies market size and is expected to continue this
trend owing to higher number of R&D activities, presence of skilled technicians,
and wide availability of technologically advanced biomarker testing instruments
and high prevalence of disease such as cancer, infectious diseases,
neurological disorders, autoimmune diseases, and others. On the other side,
Asia-Pacific is estimated to register the fastest growth during the forecast
period.
Browse Full Report & TOC: https://www.kdmarketinsights.com/product/biomarker-technologies-market-amr
Key Findings of the Biomarker
Technologies Market:
- Consumables occupied two-third share of the
market in 2019.
- The next generation sequencing segment is anticipated to grow with the highest CAGR throughout the forecast period.
- The drug discovery segment accounted for half share of the global biomarker technologies market in 2019.
- The cardiovascular disorders segment is anticipated to grow at the highest rate during the analysis period.
- The next generation sequencing segment is anticipated to grow with the highest CAGR throughout the forecast period.
- The drug discovery segment accounted for half share of the global biomarker technologies market in 2019.
- The cardiovascular disorders segment is anticipated to grow at the highest rate during the analysis period.
The major companies profiled in this report
include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La
Roche AG, Illumina, Inc., LI-COR, Inc., Merck KGAA, PerkinElmer Inc., QIAGEN,
Shimadzu Corporation, and Thermo Fisher Scientific, Inc.
About Us:
KD Market
Insights is one of the leading providers of market intelligence products
and services. We offer reports on over 10+ industries and update our collection
daily which helps our clients to access database of expert market insights on
global industries, companies, products, and trends.
Our
in-house research experts have a wealth of knowledge in their respective
domains. With KD Market Research, you always have the choice of getting
customized report free of cost (upto 10%). Our support team will help you
customize the report and scope as per your business needs. This ensures that
you are making the right purchase decision. Our clients list includes various
Fortune 500 companies and leading advisory firms.
Contact Us:
KD
Market Insights
90
State Street, Albany,
New
York, USA 12207
+1
(519) 300-1215
Comments
Post a Comment